Emerging role of PI3K/AKT in tumor-related epigenetic regulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging role of PI3K/AKT in tumor-related epigenetic regulation

Published:2019-12 Issue: Volume:59 Page:112-124
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Yang Qi,Jiang Wei,Hou Peng

Funder

Clinical Research Award of the First Affiliated Hospital of Xi’an Jiaotong University

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research

Reference217 articles.

1. The role of chromatin during transcription;Li;Cell,2007

2. Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes;Farthing;PLoS Genet.,2008

3. Epigenetics and the environmental regulation of the genome and its function;Zhang;Annu. Rev. Psychol.,2010

4. Epigenetic reprogramming in cancer;Suva;Science,2013

5. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression;Feinberg;Nat. Rev. Genet.,2016

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wogonin mitigates acetaminophen-induced liver injury in mice through inhibition of the PI3K/AKT signaling pathway;Journal of Ethnopharmacology;2024-10

2. FDA-approved antivirals ledipasvir and daclatasvir downregulate the Src-EPHA2-Akt oncogenic pathway in colorectal and triple-negative breast cancer cells;Biomedicine & Pharmacotherapy;2024-10

3. Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy;Discover Oncology;2024-08-11

4. DDX19A promotes gastric cancer cell proliferation and migration by activating the PI3K/AKT pathway;Cancer Cell International;2024-08-03

5. CDK12 is a promising therapeutic target for the transcription cycle and DNA damage response in metastatic osteosarcoma;Carcinogenesis;2024-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3